Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2026-04-10 @ 3:11 AM
Study NCT ID:
NCT06668103
Status:
RECRUITING
Last Update Posted:
2024-12-12
First Post:
2024-10-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
Sponsor:
Abbisko Therapeutics Co, Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-Small Cell Lung Cancer With EGFR Mutation | View |
Keywords: